Publications

1. Carlisle TC, Bateman JR, Yang Y, Lachner C, Stockbridge MD, Flashman LA, Chemali Z, Alzbeidi N, Pressman PS, Osibajo AM, Bobrin BD, Martinez-Menendez CJ, Teixeira AL, Daffner KR, American Neuropsychiatric Association Dementia Special Interest Group. Antiamyloid Monoclonal Antibodies in Alzheimer's Disease Part 2: Challenges in Dementia Care Delivery System Logistics. J Neuropsychiatry Clin Neurosci. 2025 Jun 26; appineuropsych20240203 Epub 2025 June 26
   View PubMed
2. Carlisle TC, Bateman JR, Yang Y, Lachner C, Stockbridge MD, Flashman LA, Chemali Z, Alzbeidi N, Pressman PS, Osibajo AM, Bobrin BD, Martinez-Menendez CJ, Teixeira AL, Daffner KR, American Neuropsychiatric Association Dementia Special Interest Group. Antiamyloid Monoclonal Antibodies in Alzheimer's Disease Part 2: Challenges in Dementia Care Delivery System Logistics. J Neuropsychiatry Clin Neurosci. 2025 Jun 26; appineuropsych20240203 Epub 2025 June 26
   View PubMed
3. Piura YD, Figdore DJ, Lachner C, Bornhorst J, Algeciras-Schimnich A, Graff-Radford NR, Day GS. Diagnostic performance of plasma p-tau217 and Aß42/40 biomarkers in the outpatient memory clinic. Alzheimers Dement. 2025 Jun; 21(6):e70316.
   View PubMed
4. Piura YD, Figdore DJ, Lachner C, Bornhorst J, Algeciras-Schimnich A, Graff-Radford NR, Day GS. Diagnostic performance of plasma p-tau217 and Aß42/40 biomarkers in the outpatient memory clinic. Alzheimers Dement. 2025 Jun; 21(6):e70316.
   View PubMed
5. Bateman JR, Carlisle TC, Yang Y, Lachner C, Stockbridge MD, Flashman LA, Chemali Z, Alzbeidi N, Pressman PS, Osibajo AM, Bobrin BD, Martinez-Menendez CJ, Teixeira AL, Daffner KR, American Neuropsychiatric Association Dementia Special Interest Group. Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 1: Patient Selection. J Neuropsychiatry Clin Neurosci. 2025 May 5; appineuropsych20240191 Epub 2025 May 05
   View PubMed
6. Bateman JR, Carlisle TC, Yang Y, Lachner C, Stockbridge MD, Flashman LA, Chemali Z, Alzbeidi N, Pressman PS, Osibajo AM, Bobrin BD, Martinez-Menendez CJ, Teixeira AL, Daffner KR, American Neuropsychiatric Association Dementia Special Interest Group. Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 1: Patient Selection. J Neuropsychiatry Clin Neurosci. 2025 May 5; appineuropsych20240191 Epub 2025 May 05
   View PubMed
7. Nissim NR, Fudge MR, Lachner C, Babulal GM, Allyse MA, Graff-Radford NR, Lucas JA, Day GS. Age-Specific Barriers and Facilitators to Research Participation Amongst African Americans in Observational Studies of Memory and Aging. J Racial Ethn Health Disparities. 2024 Oct; 11 (5):2796-2805 Epub 2023 Aug 09
   View PubMed
8. Nissim NR, Fudge MR, Lachner C, Babulal GM, Allyse MA, Graff-Radford NR, Lucas JA, Day GS. Age-Specific Barriers and Facilitators to Research Participation Amongst African Americans in Observational Studies of Memory and Aging. J Racial Ethn Health Disparities. 2024 Oct; 11 (5):2796-2805 Epub 2023 Aug 09
   View PubMed
9. Li W, Petersen RC, Algeciras-Schimnich A, Cogswell PM, Bornhorst JA, Kremers WK, Boeve BF, Jones DT, Botha H, Ramanan VK, Knopman DS, Savica R, Josephs KA, Cliatt-Brown C, Andersen E, Day GS, Graff-Radford NR, Ertekin-Taner N, Lachner C, Wicklund M, van Harten A, Woodruff BK, Caselli RJ, Graff-Radford J. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice. Mayo Clin Proc. 2024 Aug; 99 (8):1284-1296 Epub 2024 June 25
   View PubMed
10. Li W, Petersen RC, Algeciras-Schimnich A, Cogswell PM, Bornhorst JA, Kremers WK, Boeve BF, Jones DT, Botha H, Ramanan VK, Knopman DS, Savica R, Josephs KA, Cliatt-Brown C, Andersen E, Day GS, Graff-Radford NR, Ertekin-Taner N, Lachner C, Wicklund M, van Harten A, Woodruff BK, Caselli RJ, Graff-Radford J. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice. Mayo Clin Proc. 2024 Aug; 99 (8):1284-1296 Epub 2024 June 25
    View PubMed
11. Wright MA, Guasp M, Lachner C, Day GS, Gombolay G, Titulaer MJ, Clardy SL. Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature. J Neuroimmunol 2024 Jul 15; 392:578369 Epub 2024 May 14
    View PubMed
12. Wright MA, Guasp M, Lachner C, Day GS, Gombolay G, Titulaer MJ, Clardy SL. Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature. J Neuroimmunol 2024 Jul 15; 392:578369 Epub 2024 May 14
    View PubMed
13. Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, Pottier C, Wickland DP, Caetano-Anolles K, Corriveau-Lecavalier N, Tranovich JF, Wood AC, Hinkle KM, Lincoln SJ, Spychalla AJ, Senjem ML, Przybelski SA, Engelberg-Cook E, Schwarz CG, Kwan RS, Lesser ER, Crook JE, Carter RE, Ross OA, Lachner C, Ertekin-Taner N, Ferman TJ, Fields JA, Machulda MM, Ramanan VK, Nguyen AT, Reichard RR, Jones DT, Graff-Radford J, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Day GS, Duara R, Graff-Radford NR, Dickson DW, Lowe VJ, Vemuri P, Murray ME. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. JAMA Neurol. 2024 Jun 1; 81 (6):619-629
    View PubMed
14. Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, Pottier C, Wickland DP, Caetano-Anolles K, Corriveau-Lecavalier N, Tranovich JF, Wood AC, Hinkle KM, Lincoln SJ, Spychalla AJ, Senjem ML, Przybelski SA, Engelberg-Cook E, Schwarz CG, Kwan RS, Lesser ER, Crook JE, Carter RE, Ross OA, Lachner C, Ertekin-Taner N, Ferman TJ, Fields JA, Machulda MM, Ramanan VK, Nguyen AT, Reichard RR, Jones DT, Graff-Radford J, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Day GS, Duara R, Graff-Radford NR, Dickson DW, Lowe VJ, Vemuri P, Murray ME. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. JAMA Neurol. 2024 Jun 1; 81 (6):619-629
    View PubMed
15. Lachner C, Craver EC, Babulal GM, Lucas JA, Ferman TJ, White RO, Graff-Radford NR, Day GS. Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans. Ann Neurol. 2024 Mar; 95 (3):518-529 Epub 2024 Jan 09
    View PubMed
16. Lachner C, Craver EC, Babulal GM, Lucas JA, Ferman TJ, White RO, Graff-Radford NR, Day GS. Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans. Ann Neurol. 2024 Mar; 95 (3):518-529 Epub 2024 Jan 09
    View PubMed
17. Armstrong MJ, Bedenfield N, Rosselli M, Curiel Cid RE, Kitaigorodsky M, Galvin JE, Lachner C, Grant Smith A, de Los Angeles Ortega M, Mohiuddin Y, Shatzer J, Marasco D, Willis D, Bylund CL. Best Practices for Communicating a Diagnosis of Dementia: Results of a Multi-Stakeholder Modified Delphi Consensus Process. Neurol Clin Pract. 2024 Feb; 14 (1):e200223 Epub 2023 Dec 20
    View PubMed
18. Armstrong MJ, Bedenfield N, Rosselli M, Curiel Cid RE, Kitaigorodsky M, Galvin JE, Lachner C, Grant Smith A, de Los Angeles Ortega M, Mohiuddin Y, Shatzer J, Marasco D, Willis D, Bylund CL. Best Practices for Communicating a Diagnosis of Dementia: Results of a Multi-Stakeholder Modified Delphi Consensus Process. Neurol Clin Pract. 2024 Feb; 14 (1):e200223 Epub 2023 Dec 20
    View PubMed
19. Lachner C, Roemer SF, Frontera NL, Li Z, White LJ, Olson JE, Pottier CP, Dickson DW, Graff-Radford NR. Clinical Manifestations. Alzheimers Dement. 2023 Dec; 19 Suppl 18:e080355
    View PubMed
20. Lachner C, Roemer SF, Frontera NL, Li Z, White LJ, Olson JE, Pottier CP, Dickson DW, Graff-Radford NR. Clinical Manifestations. Alzheimers Dement. 2023 Dec; 19 Suppl 18:e080355
    View PubMed
21. Ramanan VK, Graff-Radford J, Syrjanen J, Shir D, Algeciras-Schimnich A, Lucas J, Martens YA, Carrasquillo MM, Day GS, Ertekin-Taner N, Lachner C, Willis FB, Knopman DS, Jack CR Jr, Petersen RC, Vemuri P, Graff-Radford N, Mielke MM. Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. Neurology. 2023 Oct 3; 101 (14):e1402-e1411 Epub 2023 Aug 14
    View PubMed
22. Boon BDC, Labuzan SA, Peng Z, Matchett BJ, Kouri N, Hinkle KM, Lachner C, Ross OA, Ertekin-Taner N, Carter RE, Ferman TJ, Duara R, Dickson DW, Graff-Radford NR, Murray ME. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes. Neurology. 2023 Oct 3; 101 (14):e1412-e1423 Epub 2023 Aug 14
    View PubMed
23. Ramanan VK, Graff-Radford J, Syrjanen J, Shir D, Algeciras-Schimnich A, Lucas J, Martens YA, Carrasquillo MM, Day GS, Ertekin-Taner N, Lachner C, Willis FB, Knopman DS, Jack CR Jr, Petersen RC, Vemuri P, Graff-Radford N, Mielke MM. Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. Neurology. 2023 Oct 3; 101 (14):e1402-e1411 Epub 2023 Aug 14
    View PubMed
24. Boon BDC, Labuzan SA, Peng Z, Matchett BJ, Kouri N, Hinkle KM, Lachner C, Ross OA, Ertekin-Taner N, Carter RE, Ferman TJ, Duara R, Dickson DW, Graff-Radford NR, Murray ME. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes. Neurology. 2023 Oct 3; 101 (14):e1412-e1423 Epub 2023 Aug 14
    View PubMed
25. Moloney CM, Labuzan SA, Crook JE, Siddiqui H, Castanedes-Casey M, Lachner C, Petersen RC, Duara R, Graff-Radford NR, Dickson DW, Mielke MM, Murray ME. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Alzheimers Dement. 2023 Mar; 19 (3):1029-1040 Epub 2022 Aug 03
    View PubMed
26. Moloney CM, Labuzan SA, Crook JE, Siddiqui H, Castanedes-Casey M, Lachner C, Petersen RC, Duara R, Graff-Radford NR, Dickson DW, Mielke MM, Murray ME. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Alzheimers Dement. 2023 Mar; 19 (3):1029-1040 Epub 2022 Aug 03
    View PubMed
27. Smith RJ, Lachner C, Singh VP, Trivedi S, Khatua B, Cartin-Ceba R. Cytokine profiles in intensive care unit delirium. Acute Crit Care. 2022 Aug; 37 (3):415-428 Epub 2022 June 20
    View PubMed
28. Smith RJ, Lachner C, Singh VP, Trivedi S, Khatua B, Cartin-Ceba R. Cytokine profiles in intensive care unit delirium. Acute Crit Care. 2022 Aug; 37 (3):415-428 Epub 2022 June 20
    View PubMed
29. Smith RJ, Rabinstein AA, Cartin-Ceba R, Singh VP, Lachner C, Khatua B, Trivedi S, Gajic O. Chemokines in ICU Delirium: An Exploratory Study. Crit Care Explor. 2022 Jul; 4 (7):e0729 Epub 2022 July 05
    View PubMed
30. Smith RJ, Rabinstein AA, Cartin-Ceba R, Singh VP, Lachner C, Khatua B, Trivedi S, Gajic O. Chemokines in ICU Delirium: An Exploratory Study. Crit Care Explor. 2022 Jul; 4 (7):e0729 Epub 2022 July 05
    View PubMed
31. Choudhury P, Graff-Radford J, Aakre JA, Wurtz L, Knopman DS, Graff-Radford NR, Kantarci K, Forsberg LK, Fields JA, Pedraza O, Chen Q, Miyagawa T, Day GS, Tipton P, Savica R, Botha H, Lachner C, Dredla B, Reichard RR, Petersen RC, Dickson DW, Boeve BF, Ferman TJ. The temporal onset of the core features in dementia with Lewy bodies. Alzheimers Dement. 2022 Apr; 18(4):591-601. Epub 2021 Nov 11.
    View PubMed
32. Choudhury P, Graff-Radford J, Aakre JA, Wurtz L, Knopman DS, Graff-Radford NR, Kantarci K, Forsberg LK, Fields JA, Pedraza O, Chen Q, Miyagawa T, Day GS, Tipton P, Savica R, Botha H, Lachner C, Dredla B, Reichard RR, Petersen RC, Dickson DW, Boeve BF, Ferman TJ. The temporal onset of the core features in dementia with Lewy bodies. Alzheimers Dement. 2022 Apr; 18(4):591-601. Epub 2021 Nov 11.
    View PubMed
33. Smith RJ, Lachner C, Singh VP, Cartin-Ceba R. Intensive care unit delirium in patients with severe COVID-19: A prospective observational cohort study. Int J Crit Illn Inj Sci. 2022 Apr-Jun; 12 (2):61-69 Epub 2022 June 24
    View PubMed
34. Smith RJ, Lachner C, Singh VP, Cartin-Ceba R. Intensive care unit delirium in patients with severe COVID-19: A prospective observational cohort study. Int J Crit Illn Inj Sci. 2022 Apr-Jun; 12 (2):61-69 Epub 2022 June 24
    View PubMed
35. Lachner C, Day GS, Camsari GB, Kouri N, Ertekin-Taner N, Boeve BF, Labuzan SA, Lucas JA, Thompson EA, Siddiqui H, Crook JE, Cabrera-Rodriguez JN, Josephs KA, Petersen RC, Dickson DW, Reichard RR, Mielke MM, Knopman DS, Graff-Radford NR, Murray ME. Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old. J Alzheimers Dis. 2022; 90 (1):405-417
    View PubMed
36. Lachner C, Day GS, Camsari GB, Kouri N, Ertekin-Taner N, Boeve BF, Labuzan SA, Lucas JA, Thompson EA, Siddiqui H, Crook JE, Cabrera-Rodriguez JN, Josephs KA, Petersen RC, Dickson DW, Reichard RR, Mielke MM, Knopman DS, Graff-Radford NR, Murray ME. Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old. J Alzheimers Dis. 2022; 90 (1):405-417
    View PubMed
37. Chipi PY, Burton MC, Vijapura P, Lachner C, Vadeboncoeur TF, Pagali SR, Maniaci MJ. Older adults on involuntary hold status in the emergency department. Am J Emerg Med. 2021 Jul; 45:242-247 Epub 2020 Aug 17
    View PubMed
38. Chipi PY, Burton MC, Vijapura P, Lachner C, Vadeboncoeur TF, Pagali SR, Maniaci MJ. Older adults on involuntary hold status in the emergency department. Am J Emerg Med. 2021 Jul; 45:242-247 Epub 2020 Aug 17
    View PubMed
39. Maniaci MJ, Lachner C, Vadeboncoeur TF, Hodge DO, Dawson NL, Rummans TA, Roy A, Burton MC. Involuntary patient length-of-stay at a suburban emergency department. Am J Emerg Med. 2020 Mar; 38 (3):534-538 Epub 2019 May 24
    View PubMed
40. Maniaci MJ, Lachner C, Vadeboncoeur TF, Hodge DO, Dawson NL, Rummans TA, Roy A, Burton MC. Involuntary patient length-of-stay at a suburban emergency department. Am J Emerg Med. 2020 Mar; 38 (3):534-538 Epub 2019 May 24
    View PubMed
41. Lachner C, Maniaci MJ, Vadeboncoeur TF, Dawson NL, Rummans TA, Roy A, Hall LL, Burton MC. Are pre-existing psychiatric disorders the only reason for involuntary holds in the emergency department? Int J Emerg Med. 2020 Feb 3; 13 (1):4 Epub 2020 Feb 03
    View PubMed
42. Lachner C, Maniaci MJ, Vadeboncoeur TF, Dawson NL, Rummans TA, Roy A, Hall LL, Burton MC. Are pre-existing psychiatric disorders the only reason for involuntary holds in the emergency department? Int J Emerg Med. 2020 Feb 3; 13 (1):4 Epub 2020 Feb 03
    View PubMed
43. McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's Disease. J Huntingtons Dis. 2020; 9 (1):47-58
    View PubMed
44. McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's Disease. J Huntingtons Dis. 2020; 9 (1):47-58
    View PubMed
45. Maniaci MJ, Burton MC, Lachner C, Vadeboncoeur TF, Dawson NL, Roy A, Dumitrascu AG, Lewis PC, Rummans TA. Patients Threatening Harm to Others Evaluated in the Emergency Department under the Florida Involuntary Hold Act (Baker Act). South Med J. 2019 Sep; 112 (9):463-468
    View PubMed
46. Maniaci MJ, Burton MC, Lachner C, Vadeboncoeur TF, Dawson NL, Roy A, Dumitrascu AG, Lewis PC, Rummans TA. Patients Threatening Harm to Others Evaluated in the Emergency Department under the Florida Involuntary Hold Act (Baker Act). South Med J. 2019 Sep; 112 (9):463-468
    View PubMed
47. Roy A, Lachner C, Dumitrascu A, Dawson NL, Vadeboncoeur TF, Maniaci MJ, Lamoureux IC, Lewis PC, Rummans TA, Burton MC. Patients on Involuntary Hold Status in the Emergency Department. South Med J. 2019 May; 112 (5):265-270
    View PubMed
48. Roy A, Lachner C, Dumitrascu A, Dawson NL, Vadeboncoeur TF, Maniaci MJ, Lamoureux IC, Lewis PC, Rummans TA, Burton MC. Patients on Involuntary Hold Status in the Emergency Department. South Med J. 2019 May; 112 (5):265-270
    View PubMed
49. McGarry A, McDermott MP, Kieburtz K, Fung WLA, McCusker E, Peng J, de Blieck EA, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial. Neurology. 2019 Apr 02; 92(14):e1643-e1651. Epub 2019 Mar 08.
    View PubMed
50. McGarry A, McDermott MP, Kieburtz K, Fung WLA, McCusker E, Peng J, de Blieck EA, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial. Neurology. 2019 Apr 02; 92(14):e1643-e1651. Epub 2019 Mar 08.
    View PubMed
51. Bobo WV, Grossardt BR, Lapid MI, Leung JG, Stoppel C, Takahashi PY, Hoel RW, Chang Z, Lachner C, Chauhan M, Flowers L, Brue SM, Frye MA, St Sauver J, Rocca WA, Sutor B. Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. population. Pharmacol Res Perspect. 2019 Feb; 7 (1):e00461 Epub 2019 Jan 23
    View PubMed
52. Bobo WV, Grossardt BR, Lapid MI, Leung JG, Stoppel C, Takahashi PY, Hoel RW, Chang Z, Lachner C, Chauhan M, Flowers L, Brue SM, Frye MA, St Sauver J, Rocca WA, Sutor B. Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. population. Pharmacol Res Perspect. 2019 Feb; 7 (1):e00461 Epub 2019 Jan 23
    View PubMed
53. Schmidt KA, Lamoureux IC, Schak KM, Lachner C, Burton MC, Larrabee BR, Rummans TA. Substance use disorders and their effect on the psychiatric and justice systems. Am J Addict. 2018 Oct; 27 (7):574-577 Epub 2018 Aug 28
    View PubMed
54. Schmidt KA, Lamoureux IC, Schak KM, Lachner C, Burton MC, Larrabee BR, Rummans TA. Substance use disorders and their effect on the psychiatric and justice systems. Am J Addict. 2018 Oct; 27 (7):574-577 Epub 2018 Aug 28
    View PubMed
55. Dawson NL, Lachner C, Vadeboncoeur TF, Maniaci MJ, Bosworth V, Rummans TA, Roy A, Burton MC. Violent behavior by emergency department patients with an involuntary hold status. Am J Emerg Med. 2018 Mar; 36 (3):392-395 Epub 2017 Aug 18
    View PubMed
56. Dawson NL, Lachner C, Vadeboncoeur TF, Maniaci MJ, Bosworth V, Rummans TA, Roy A, Burton MC. Violent behavior by emergency department patients with an involuntary hold status. Am J Emerg Med. 2018 Mar; 36 (3):392-395 Epub 2017 Aug 18
    View PubMed
57. Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ, TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology. 2017 Dec 12; 89 (24):2495-2502 Epub 2017 Nov 15
    View PubMed
58. Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ, TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology. 2017 Dec 12; 89 (24):2495-2502 Epub 2017 Nov 15
    View PubMed
59. Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD, Huntington Study Group CREST-E Investigators and Coordinators. The CREST-E study of creatine for Huntington disease: A randomized controlled trial. Neurology. 2017 Aug 8; 89 (6):594-601 Epub 2017 July 12
    View PubMed
60. Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD, Huntington Study Group CREST-E Investigators and Coordinators. The CREST-E study of creatine for Huntington disease: A randomized controlled trial. Neurology. 2017 Aug 8; 89 (6):594-601 Epub 2017 July 12
    View PubMed
61. Lachner C, Armstrong MJ, Gruber-Baldini AL, Rezvani Z, Reich SG, Fishman PS, Salazar R, Shulman LM. Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson Disease. J Geriatr Psychiatry Neurol. 2017 Jul; 30 (4):191-195 Epub 2017 May 24
    View PubMed
62. Lachner C, Armstrong MJ, Gruber-Baldini AL, Rezvani Z, Reich SG, Fishman PS, Salazar R, Shulman LM. Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson Disease. J Geriatr Psychiatry Neurol. 2017 Jul; 30 (4):191-195 Epub 2017 May 24
    View PubMed
63. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88 (2):152-159 Epub 2016 Dec 02
    View PubMed
64. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88 (2):152-159 Epub 2016 Dec 02
    View PubMed
65. Armstrong MJ, Gruber-Baldini AL, Reich SG, Fishman PS, Lachner C, Shulman LM. Which features of Parkinson's disease predict earlier exit from the workforce? Parkinsonism Relat Disord. 2014 Nov; 20(11):1257-9. Epub 2014 Aug 20.
    View PubMed
66. Armstrong MJ, Gruber-Baldini AL, Reich SG, Fishman PS, Lachner C, Shulman LM. Which features of Parkinson's disease predict earlier exit from the workforce? Parkinsonism Relat Disord. 2014 Nov; 20(11):1257-9. Epub 2014 Aug 20.
    View PubMed
67. Lachner C, Martin C, John D, Nekkalapu S, Sasan A, Steinle N, Regenold WT. Older adult psychiatric inpatients with non-cognitive disorders should be screened for vitamin B12 deficiency. J Nutr Health Aging. 2014; 18(2):209-12.
    View PubMed
68. Lachner C, Martin C, John D, Nekkalapu S, Sasan A, Steinle N, Regenold WT. Older adult psychiatric inpatients with non-cognitive disorders should be screened for vitamin B12 deficiency. J Nutr Health Aging. 2014; 18(2):209-12.
    View PubMed
69. Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):5-15.
    View PubMed
70. Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):5-15.
    View PubMed
71. Lachner C, Sandson NB. Medical complications of catatonia: a case of catatonia-induced deep venous thrombosis. Psychosomatics. 2003 Nov-Dec; 44(6):512-4.
    View PubMed
72. Lachner C, Sandson NB. Medical complications of catatonia: a case of catatonia-induced deep venous thrombosis. Psychosomatics. 2003 Nov-Dec; 44(6):512-4.
    View PubMed